Facebook
Twitter
Telegram
Report an ErrorNovaBay Pharmaceuticals Financial Ratios 2011-2024 | NBY
Annual Financial Ratios NovaBay Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-0.1 | -0.2 | -0.1 | -3.2 | -1.4 | -4.9 | -7.7 | -2.8 | -0.4 | -2.1 | -2.7 | -5.4 | -7.1 |
P/S |
0.0 | 0.2 | 0.0 | 3.6 | 2.0 | 2.6 | 3.1 | 3.0 | 1.6 | 30.1 | 12.5 | 5.5 | 3.3 |
EPS |
-4.0 | -10.1 | -5.3 | -0.3 | -0.5 | -0.4 | -0.5 | -1.4 | -6.8 | -7.7 | -10.5 | -0.2 | -0.2 |
EV (Enterprise Value) |
3.18 M | 2.96 M | 6.78 M | 26.6 M | 16.5 M | 33.5 M | 61 M | 35 M | 15 M | 32 M | 40.2 M | 30.4 M | 34.3 M |
EBITDA per Share |
-1.79 | -8.88 | -7.06 | -0.159 | -0.431 | -0.449 | -0.471 | -1.16 | -7.49 | -8.39 | -9.93 | -6.76 | -3.78 |
EV/EBITDA |
-0.7 | -3.7 | -1.0 | -3.8 | -7.4 | -2.5 | -0.3 | -1.6 | -2.2 | -3.2 | -7.1 | ||
PEG |
-0.0 | -0.0 | -0.0 | 0.51 | 0.06 | -0.26 | -0.12 | -0.03 | -0.03 | -0.08 | 0.04 | 0.27 | 0.64 |
P/B |
0.2 | 0.2 | 0.0 | 2.9 | 13.6 | 6.5 | 21.9 | 5.1 | -1.4 | 17.2 | 5.1 | 2.7 | 3.9 |
P/CF |
-0.1 | -0.4 | -0.1 | -7.5 | -1.7 | -5.8 | -8.7 | -2.9 | -0.4 | -2.1 | -3.3 | -5.7 | -11.1 |
ROE % |
-290.89 | -100.51 | -57.26 | -89.62 | -992.60 | -132.12 | -285.39 | -185.20 | 372.17 | -822.19 | -188.37 | -50.02 | -54.42 |
ROA % |
-106.71 | -64.69 | -24.29 | -72.44 | -86.08 | -69.92 | -73.45 | -85.50 | -373.70 | -201.59 | -102.50 | -36.53 | -31.85 |
ROCE % |
-229.21 | -136.60 | -87.13 | -51.80 | -169.89 | -142.75 | -143.35 | -99.31 | -4732.88 | -402.62 | -128.80 | -51.73 | -32.92 |
Current Ratio |
1.6 | 2.8 | 1.7 | 5.0 | 1.6 | 2.2 | 1.8 | 3.3 | 1.0 | 2.1 | 4.1 | 5.8 | 5.1 |
DSO |
33.9 | 25.0 | - | 40.6 | 59.0 | 101.9 | 74.4 | 70.1 | 44.7 | 94.5 | 82.3 | 49.5 | 0.1 |
DIO |
168.7 | 183.4 | 189.4 | 55.9 | 103.3 | 68.0 | 66.1 | 129.3 | 389.3 | 391.3 | 520.5 | - | - |
DPO |
59.0 | 58.6 | 66.6 | 27.8 | 69.5 | 133.8 | 61.1 | 67.4 | 718.7 | 1400.7 | 3771.7 | - | - |
Operating Cycle |
202.6 | 208.4 | 189.4 | 96.5 | 162.3 | 169.9 | 140.5 | 199.4 | 434.0 | 485.8 | 602.8 | - | - |
Cash Conversion Cycle |
143.5 | 149.9 | 122.7 | 68.8 | 92.8 | 36.1 | 79.4 | 132.0 | -284.7 | -914.8 | -3168.9 | - | - |
All numbers in USD currency
Quarterly Financial Ratios NovaBay Pharmaceuticals
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS |
-0.37 | -1.27 | -0.85 | - | -3.61 | -1.43 | -0.08 | - | -0.05 | -0.04 | -0.04 | - | -0.08 | -0.15 | -0.06 | - | -0.01 | -0.14 | -0.25 | - | -0.09 | -0.09 | -0.13 | - | -0.16 | -0.11 | -0.26 | - | -0.34 | -0.36 | -1.24 | - | -1.77 | -1.84 | -2.13 | - | -0.08 | -0.06 | -0.08 | - | -0.1 | -0.11 | -0.11 | - | - | -0.08 | -0.09 | - | - | 0.02 | -0.08 |
EBITDA per Share |
-0.24 | -0.42 | -0.85 | - | -0.27 | -1.41 | -1.64 | - | -0.05 | -0.04 | -0.04 | - | -0.05 | -0.03 | -0.05 | - | -0.07 | -0.07 | -0.24 | - | -0.1 | -0.12 | -0.14 | - | -0.14 | -0.11 | -0.25 | - | -0.19 | -0.3 | -1.13 | - | - | - | -2.12 | - | -0.08 | -0.07 | -0.09 | - | -0.07 | -0.11 | -0.02 | - | 0.01 | -0.09 | -0.08 | - | - | 0.03 | -0.08 |
ROE % |
-69.29 | -45.31 | -35.22 | -15.30 | -39.74 | -63.20 | -66.10 | -54.85 | -81.00 | -82.70 | -102.50 | -75.38 | -104.36 | -107.19 | -327.85 | -716.55 | -747.59 | -749.66 | -524.69 | -106.52 | -240.09 | -342.61 | -377.54 | -355.20 | -407.81 | -326.85 | -297.73 | -161.99 | -59.17 | 96.27 | 230.01 | -17.23 | -245.53 | -576.65 | -831.72 | -580.41 | -625.60 | -442.48 | -330.82 | -796.31 | -795.74 | -749.99 | -718.30 | -33.29 | -32.16 | -31.59 | -11.20 | -15.59 | 1.13 | 4.55 | -21.28 |
ROA % |
-38.73 | -25.66 | -22.95 | -11.06 | -29.76 | -47.86 | -51.52 | -43.16 | -64.29 | -66.73 | -82.48 | -60.93 | -63.45 | -44.82 | -37.70 | -62.14 | -78.57 | -92.49 | -87.17 | -56.37 | -80.65 | -88.50 | -88.77 | -81.32 | -105.61 | -105.62 | -105.86 | -74.79 | -178.04 | -257.00 | -335.77 | -256.41 | -312.38 | -265.11 | -207.89 | -142.31 | -166.90 | -135.51 | -122.34 | -433.32 | -432.90 | -407.90 | -393.60 | -24.32 | -23.65 | -23.40 | -9.17 | -9.13 | 0.66 | 2.66 | -12.45 |
ROCE % |
-54.50 | -41.96 | -39.80 | -30.41 | -54.85 | -75.98 | -78.90 | -54.87 | -71.61 | -63.90 | -56.01 | -37.90 | -213.85 | -373.06 | -506.09 | -736.07 | -772.59 | -633.16 | -533.48 | -126.36 | -244.76 | -326.64 | -352.32 | -331.73 | -360.76 | -271.39 | -235.20 | -126.07 | -21.16 | 112.77 | 239.62 | -16.68 | -239.24 | -566.71 | -866.89 | -648.11 | -683.12 | -495.57 | -339.44 | -124.69 | -125.45 | -91.19 | -62.92 | -38.91 | -42.63 | -45.60 | -20.43 | -19.83 | -3.72 | 4.71 | -20.82 |
Current Ratio |
2.2 | 2.1 | 2.5 | 2.8 | 2.6 | 3.7 | 3.5 | 1.7 | 4.3 | 5.7 | 4.6 | 5.2 | 5.2 | 5.2 | 5.2 | 1.1 | 1.1 | 1.1 | 1.1 | 2.1 | 2.1 | 2.1 | 2.1 | 1.4 | 1.4 | 1.4 | 1.4 | 1.9 | 1.9 | 1.9 | 1.9 | 0.5 | 0.5 | 0.5 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 2.2 | 2.2 | 2.2 | 2.2 | 3.7 | 3.7 | 3.7 | 3.7 | 2.4 | 2.4 | 2.4 | 2.4 |
DSO |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DIO |
228.7 | 147.7 | 277.8 | - | 247.4 | 181.1 | 208.2 | - | 105.8 | 113.8 | 146.2 | - | 103.5 | 27.2 | 86.4 | - | 112.0 | 111.4 | 103.3 | - | 77.0 | 53.3 | 142.5 | - | 88.3 | 65.9 | 106.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
DPO |
77.6 | 52.1 | 85.6 | - | 63.7 | 62.2 | 81.3 | - | 100.1 | 77.3 | 113.8 | - | 51.4 | 13.5 | 49.7 | - | 75.3 | 75.0 | 118.0 | - | 151.4 | 105.0 | 184.9 | - | 81.6 | 60.9 | 71.5 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Operating Cycle |
228.7 | 147.7 | 277.8 | - | 247.4 | 181.1 | 208.2 | - | 105.8 | 113.8 | 146.2 | - | 103.5 | 27.2 | 86.4 | - | 112.0 | 111.4 | 103.3 | - | 77.0 | 53.3 | 142.5 | - | 88.3 | 65.9 | 106.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cash Conversion Cycle |
151.1 | 95.6 | 192.2 | - | 183.7 | 118.9 | 126.8 | - | 5.7 | 36.5 | 32.4 | - | 52.1 | 13.7 | 36.7 | - | 36.6 | 36.5 | -14.7 | - | -74.5 | -51.6 | -42.4 | - | 6.7 | 5.0 | 35.4 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency